Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization

BACKGROUND: Overexpression or mutation of the epidermal growth factor receptor (EGFR) potently enhances the growth of many solid tumors. Tumor cells frequently display resistance to mechanistically-distinct EGFR-directed therapeutic agents, making it valuable to develop therapeutics that work by add...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez, Ursula D., Nikonova, Anna S., Liu, Hanqing, Pecherskaya, Anna, Lawrence, Sarah H., Serebriiskii, Ilya G., Zhou, Yan, Robinson, Matthew K., Einarson, Margret B., Golemis, Erica A., Jaffe, Eileen K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451962/
https://www.ncbi.nlm.nih.gov/pubmed/26016476
http://dx.doi.org/10.1186/s12885-015-1415-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451962/
https://www.ncbi.nlm.nih.gov/pubmed/26016476
http://dx.doi.org/10.1186/s12885-015-1415-6

Ejemplares similares